Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Last updated: November 14, 2024
Sponsor: M.D. Anderson Cancer Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Cancer

Non-small Cell Lung Cancer

Cancer

Treatment

Cancer-Related Discussion Program

Meditation and Discussion Sessions

Questionnaires

Clinical Study ID

NCT02596490
2015-0275
NCI-2015-02128
1R21CA191711
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Objectives:

Our specific aims are to:

Aim 1: Examine the feasibility of a couple-based meditation program in 50 patients with metastatic lung cancer and their partners.

Aim 2: Establish the initial efficacy of a couple-based meditation program in patients and their partners regarding physical, psychological, and spiritual quality of life outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. ALL PHASES, PATIENTS ONLY: Diagnosed with stage IV Non-Small Cell Lung Cancer (NSCLC)

  2. ALL PHASES, PATIENTS ONLY: Currently receiving treatment (e.g. radiotherapy,chemotherapy) at MD Anderson Cancer Center

  3. ALL PHASES, PATIENTS ONLY: Eastern Cooperative Oncology Group (ECOG) performancestatus of less than or equal to 2

  4. ALL PHASES, PATIENTS ONLY: Have a romantic partner with whom they have resided for aminimum of 6 months

  5. ALL PHASES, PATIENTS AND PARTNERS: Must be at least 18 years old

  6. ALL PHASES, PATIENTS AND PARTNERS: Able to read and speak English

  7. ALL PHASES, PATIENTS AND PARTNERS: Able to provide consent.

Exclusion

Exclusion Criteria:

  1. ALL PHASES, PATIENTS AND PARTNERS: Not oriented to time, place, or person as deemedby the clinical team

  2. ALL PHASES, PATIENTS AND PARTNERS: Regular (self-defined) participation inpsychotherapy or a formal cancer support group

  3. ALL PHASES, PATIENTS AND PARTNERS: Prior enrollment in a couple-based mind-bodyintervention research study (protocols 2011-1179, 2013-0496, 2014-0036) conducted bythe principal investigator including phase 1 or phase 2 of the current study.

Study Design

Total Participants: 300
Treatment Group(s): 3
Primary Treatment: Cancer-Related Discussion Program
Phase:
Study Start date:
April 06, 2016
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • Memorial Hermann

    Houston, Texas 77030
    United States

    Active - Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas 77030
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.